Michael Davies, CEO of Global Health caught up with Ky Chow from Proactive Investors to discuss the company's latest 4C Quarterly results.
Michael discusses the growth in our sales pipeline, the steps we are taking to re-platform and revolutionise our R&D, our successful implementation of MasterCare for the Western Australian Mental Health Commission, as well as our solid position as we head into Q4 with a strong balance sheet and an uplift in recurring revenue of 11%.